Literature DB >> 15273732

Genetic alterations of the MYH gene in gastric cancer.

Chang Jae Kim1, Yong Gu Cho, Cho Hyun Park, Su Young Kim, Suk Woo Nam, Sug Hyung Lee, Nam Jin Yoo, Jung Young Lee, Won Sang Park.   

Abstract

Increased oxygen free radicals produced in gastric mucosa by H. pylori induce DNA damage and lead to dyspalsia and gastric cancers. However, only a small percentage of individuals that carry H. pylori develop gastric cancer, indicating that other factors are involved. We have screened a set of 95 sporadic gastric cancers for mutations and allele loss of the DNA glycosylase MYH gene, which excises adenine misincorporated opposite unrepaired 8-oxoG. Two of 95 cancers had bi-allelic mutations of the MYH gene with somatic missense mutation of one allele and loss of the remaining allele. The mutations were missense mutations, P391S and Q400R, in exon 13 encoding NUDIX hydrolase domain of the gene. The patients were H. pylori-positive and the tumors were of advanced intestinal-type gastric cancer with lymph node metastasis. In addition, 4 (17.4%) of 23 informative cases showed allele loss at MYH locus. Therefore, our data suggest that somatic mutations of base excision repair gene MYH contribute to the development of a sub-set of sporadic gastric cancers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273732     DOI: 10.1038/sj.onc.1207574

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Atomic substitution reveals the structural basis for substrate adenine recognition and removal by adenine DNA glycosylase.

Authors:  Seongmin Lee; Gregory L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

2.  MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients.

Authors:  Linnea M Baudhuin; Lewis R Roberts; Felicity T B Enders; Russell L Swanson; Teresa A Mettler; Ileana Aderca; Linda M Stadheim; W Edward Highsmith
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-15       Impact factor: 4.553

Review 3.  MUTYH-associated tumor syndrome: The other face of MAP.

Authors:  Luigi Magrin; Daniele Fanale; Chiara Brando; Lidia Rita Corsini; Ugo Randazzo; Marianna Di Piazza; Vittorio Gurrera; Erika Pedone; Tancredi Didier Bazan Russo; Salvatore Vieni; Gianni Pantuso; Antonio Russo; Viviana Bazan
Journal:  Oncogene       Date:  2022-04-14       Impact factor: 9.867

4.  Alternative splicing of the FGF antisense gene: differential subcellular localization in human tissues and esophageal adenocarcinoma.

Authors:  Shuo Cheng Zhang; Christie Barclay; Leigh Ann Alexander; Laurette Geldenhuys; Geoffrey A Porter; Alan G Casson; Paul R Murphy
Journal:  J Mol Med (Berl)       Date:  2007-06-14       Impact factor: 4.599

5.  Whole exome sequencing of pediatric leukemia reveals a novel InDel within FLT-3 gene in AML patient from Mizo tribal population, Northeast India.

Authors:  Andrew Vanlallawma; Doris Lallawmzuali; Jeremy L Pautu; Vinod Scaria; Sridhar Sivasubbu; Nachimuthu Senthil Kumar
Journal:  BMC Genom Data       Date:  2022-03-28

6.  MUTYH Associated Polyposis (MAP).

Authors:  M L M Poulsen; M L Bisgaard
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

Review 7.  Familial adenomatous polyposis.

Authors:  Elizabeth Half; Dani Bercovich; Paul Rozen
Journal:  Orphanet J Rare Dis       Date:  2009-10-12       Impact factor: 4.123

8.  The polymorphic AluYb8 insertion in the MUTYH gene is associated with reduced type 1 protein expression and reduced mitochondrial DNA content.

Authors:  Wenwen Guo; Bixia Zheng; Zhenming Cai; Lizhi Xu; Dong Guo; Lili Cao; Yaping Wang
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

9.  Machine Learning and Bioinformatics Models to Identify Pathways that Mediate Influences of Welding Fumes on Cancer Progression.

Authors:  Humayan Kabir Rana; Mst Rashida Akhtar; M Babul Islam; Mohammad Boshir Ahmed; Pietro Lió; Fazlul Huq; Julian M W Quinn; Mohammad Ali Moni
Journal:  Sci Rep       Date:  2020-02-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.